CAMP Competitors & Alternatives

Compare CAMP4 THERAPEUTICS CORPORATION with similar stocks in the same industry

Biotechnology

CAMP

Main Stock
$3.95
+2.33%
Tradestie Score
42
Market Cap
$59.48M
Revenue Growth
138.9%
Analyst Upside
+158.8%

Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)

Bottleneck Score: 2/10 Drug Discovery Biotech Drug Design
Competitive Moat: None
Core Technology Stack: RAP Platform, Small molecule RNA modulators
Major Customers 3
Pharma partners Academic research institutions Future specialty clinics
Critical Suppliers 3
CROs for clinical trials Chemical synthesis vendors Sequencing service providers
Direct Ecosystem Rivals 3

Top Competitors

218 stocks in Biotechnology
Company Price Market Cap P/E Score Action
OMER Omeros Corporation
$13.70
-17.87%
$281.75M 14.3 52 Compare
DBVT DBV Technologies S.A.
$9.96
-3.02%
$275.54M - 29 Compare
VOR Vor Biopharma Inc. Common Stock
$17.99
-5.17%
$269.08M 0.1 51 Compare
VTYX Ventyx Biosciences, Inc. Common Stock
$14.00
+0.14%
$256.71M - 51 Compare
SLN Silence Therapeutics Plc American Depository Share
$19.79
-0.05%
$240.89M - 45 Compare
OABI OmniAb, Inc. Common Stock
$5.01
+2.45%
$231.77M - 56 Compare
SGMT Sagimet Biosciences Inc. Series A Common Stock
$9.73
-3.95%
$227.00M - 50 Compare
SLS SELLAS Life Sciences Group, Inc. Common Stock
$19.68
+163.41%
$211.22M - 32 Compare
ACRS Aclaris Therapeutics, Inc.
$3.39
-6.10%
$202.58M - 40 Compare
CBIO Crescent Biopharma, Inc. Common Stock
$13.30
-1.48%
$199.71M - 42 Compare

Data updated: Nov 17, 2026 | Industry: Biotechnology (SIC 2834)

218 stocks in this industry